Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nrf2 Activator PB125® as a Potential Therapeutic Agent against COVID-19

12 Jun 2020

Abstract excerpt

Nrf2 is a transcription factor that regulates cellular redox balance and the expression of a wide array of genes involved in immunity and inflammation, including antiviral actions. Nrf2 activity declines with age, making the elderly more susceptible to oxidative stress-mediated diseases, which include type 2 diabetes, chronic inflammation, and viral infections. Published evidence suggests that Nrf2 activity may...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Genomics, phytochemicals, and oxidative stress
Share to Inflammasome and immune disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32545518
DOI: 10.3390/antiox9060518

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nrf2 Activator PB125® as a Potential Therapeutic Agent against COVID-19PMID 32545518Read ↗

Nrf2 Activator PB125 <sup>®</sup> as a Potential Therapeutic Agent Against COVID-19Semantic proximity Read ↗

Nrf2 activator PB125® as a carnosic acid-based therapeutic agent against respiratory viral diseases, including COVID-19Semantic proximity Read ↗

Transcription factor Nrf2 as a potential therapeutic target for COVID-19Semantic proximity Read ↗

Identification of SARS-CoV2-mediated suppression of NRF2 signaling reveals a potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarateSemantic proximity Read ↗

Identification of SARS-CoV2-mediated suppression of NRF2 signaling reveals a potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarateSemantic proximity Read ↗

NRF2 activators restrict coronaviruses by targeting a network involving ACE2, TMPRSS2, and XPO1Semantic proximity Read ↗

Dysregulation of redox-inflammatory markers in COVID-19: A multi-parameter analysis with disease severitySemantic proximity Read ↗

Role of NRF2 and Sirtuin activators in COVID-19Semantic proximity Read ↗

Multi-target mode of action of Sulfodyne <sup>®</sup> , a stabilized Sulforaphane, against pathogenic effects of SARS-CoV-2 infectionSemantic proximity Read ↗

Pharmacological inhibition of bromodomain and extra-terminal proteins induces NRF-2-mediated inhibition of SARS-CoV-2 replication and is subject to viral antagonismSemantic proximity Read ↗

Network Pharmacology Reveals That Resveratrol Can Alleviate COVID-19-Related HyperinflammationSemantic proximity Read ↗

Integrative transcriptome analyses empower the anti-COVID-19 drug arsenalSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.